In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor

  • Subunit vaccines often require adjuvants to elicit sustained immune activity. Here, a method is described to evaluate the efficacy of single vaccine candidates in the preclinical stage based on cytokine and gene expression analysis. As a model, the recombinant human respiratory syncytial virus (RSV) fusion protein (RSV-F) was produced in CHO cells. For comparison, wild-type and glycoengineered, afucosylated RSV-F were established. Both glycoprotein vaccines were tested in a commercial Human Artificial Lymph Node in vitro model (HuALN®). The analysis of six key cytokines in cell culture supernatants showed well-balanced immune responses for the afucosylated RSV-F, while immune response of wild-type RSV-F was more Th1 accentuated. In particular, stronger and specific secretion of interleukin-4 after each round of re-stimulation underlined higher potency and efficacy of the afucosylated vaccine candidate. Comprehensive gene expression analysis by nCounter gene expression assay confirmed the stronger onset of the immunologic reaction in stimulation experiments with the afucosylated vaccine in comparison to wild-type RSV-F and particularly revealed prominent activation of Th17 related genes, innate immunity, and comprehensive activation of humoral immunity. We, therefore, show that our method is suited to distinguish the potency of two vaccine candidates with minor structural differences.

Download full text files

Export metadata

Additional Services

Search Google Scholar Statistics
Author:Lars Radke, Grit Sandig, Annika Lubitz, Ulrike Schließer, Hans Henning von Horsten, Véronique Blanchard, Karolin Keil, Volker Sandig, Christoph Giese, Michael Hummel, Stephan Hinderlich, Marcus FrohmeORCiDGND
Parent Title (English):Bioengineering
Document Type:Article
Year of Publication:2017
Publishing Institution:Technische Hochschule Wildau
Release Date:2017/08/17
Tag:F-Protein; Glycoengineering; NanoString; RSV; fucosylation
Source:Radke, L.; Sandig, G.; Lubitz, A.; Schließer, U.; von Horsten, H.H.; Blanchard, V.; Keil, K.; Sandig, V.; Giese, C.; Hummel, M.; Hinderlich, S.; Frohme, M. In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor. Bioengineering 2017, 4, 70.
Faculties an central facilities:Fachbereich Ingenieur- und Naturwissenschaften
Dewey Decimal Classification:5 Naturwissenschaften und Mathematik / 57 Biowissenschaften; Biologie / 570 Biowissenschaften; Biologie
Licence (German):Creative Commons - CC BY - Namensnennung 4.0 International
Verstanden ✔
Diese Webseite verwendet technisch erforderliche Session-Cookies. Durch die weitere Nutzung der Webseite stimmen Sie diesem zu. Unsere Datenschutzerklärung finden Sie hier.